Within an unbranded asset, if we are mentioning different treatment options/replacement therapies not by drug name but by outlining different treatment formulations and each formulation happens to have only one product out in the market, would this be allowed.
Also, if we talk about the treatment formulations, can the Product Monograph be used as a reference?
A
AP
@AP
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Posts
-
Treatment Options within an Unbranded asset -
Schedule 2 products - PAAB guidelines for promotional materialWe are marketing a Schedule 2 product (non-prescription, HC regulated) that can also be prescribed (to allow for coverage via a drug plan) and wanted to know the guidelines for branded and unbranded promotional materials when it comes to this type of Schedule 2 products.